Targeting the IspD Enzyme in the MEP Pathway: Identification of a Novel Fragment Class.

IspD MEP pathway Plasmodium falciparum drug discovery fragment

Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
04 03 2022
Historique:
revised: 14 12 2021
received: 26 10 2021
pubmed: 18 12 2021
medline: 3 5 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

The enzymes of the 2-C-methylerythritol-d-erythritol 4-phosphate (MEP) pathway (MEP pathway or non-mevalonate pathway) are responsible for the synthesis of universal precursors of the large and structurally diverse family of isoprenoids. This pathway is absent in humans, but present in many pathogenic organisms and plants, making it an attractive source of drug targets. Here, we present a high-throughput screening approach that led to the discovery of a novel fragment hit active against the third enzyme of the MEP pathway, PfIspD. A systematic SAR investigation afforded a novel chemical structure with a balanced activity-stability profile (16). Using a homology model of PfIspD, we proposed a putative binding mode for our newly identified inhibitors that sets the stage for structure-guided optimization.

Identifiants

pubmed: 34918860
doi: 10.1002/cmdc.202100679
pmc: PMC9305118
doi:

Substances chimiques

Sugar Phosphates 0
erythritol 4-phosphate 7183-41-7
Erythritol RA96B954X6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202100679

Informations de copyright

© 2021 The Authors. ChemMedChem published by Wiley-VCH GmbH.

Références

Nat Struct Biol. 2001 Jul;8(7):641-8
pubmed: 11427897
Angew Chem Int Ed Engl. 2014 Feb 17;53(8):2235-9
pubmed: 24446431
Drug Discov Today. 2013 Dec;18(23-24):1256-62
pubmed: 23856326
Chemistry. 2013 Jun 24;19(26):8397-400
pubmed: 23681768
J Med Chem. 2014 Dec 11;57(23):9740-63
pubmed: 25210872
ACS Infect Dis. 2015 Apr 10;1(4):157-167
pubmed: 26783558
Sci Rep. 2018 Dec 17;8(1):17892
pubmed: 30559447
Antimicrob Agents Chemother. 2003 Feb;47(2):735-8
pubmed: 12543685
Angew Chem Int Ed Engl. 2011 Aug 22;50(35):8077-81
pubmed: 21751313
Science. 1999 Sep 3;285(5433):1573-6
pubmed: 10477522
Microbiology (Reading). 2012 Jun;158(Pt 6):1389-1401
pubmed: 22466083
Angew Chem Int Ed Engl. 2011 Aug 16;50(34):7931-5
pubmed: 21766403
ChemMedChem. 2021 Jul 6;16(13):2089-2093
pubmed: 33844432
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11758-63
pubmed: 10518523
Clin Infect Dis. 2018 Jun 1;66(12):1823-1830
pubmed: 29293893
Chem Rev. 2017 Apr 26;117(8):5675-5703
pubmed: 27995802
Acta Crystallogr D Biol Crystallogr. 2003 Mar;59(Pt 3):607-10
pubmed: 12595740
FEBS J. 2006 Mar;273(5):1065-73
pubmed: 16478479
Acta Crystallogr D Biol Crystallogr. 2011 May;67(Pt 5):403-14
pubmed: 21543842
J Med Chem. 2010 Nov 25;53(22):7902-17
pubmed: 20804202
Nat Chem Biol. 2007 Jul;3(7):408-14
pubmed: 17576428
ChemMedChem. 2022 Mar 4;17(5):e202100679
pubmed: 34918860

Auteurs

Eleonora Diamanti (E)

Helmholtz Institute for Pharmaceutical Research (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus E8.1, 66123, Saarbrücken, Germany.
Helmholtz International Lab for Anti-Infectives, Saarland University Campus E8.1, 66123, Saarbrücken, Germany.

Mostafa M Hamed (MM)

Helmholtz Institute for Pharmaceutical Research (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus E8.1, 66123, Saarbrücken, Germany.

Antoine Lacour (A)

Helmholtz Institute for Pharmaceutical Research (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus E8.1, 66123, Saarbrücken, Germany.
Department of Pharmacy, Saarland University, Campus E8.1, 66123, Saarbrücken, Germany.

Patricia Bravo (P)

Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002, Basel, Switzerland.
Universität Basel, Petersplatz 1, 4003, Basel, Switzerland.

Boris Illarionov (B)

Hamburg School of Food Science, University of Hamburg, Grindelallee 117, 20146, Hamburg, Germany.

Markus Fischer (M)

Hamburg School of Food Science, University of Hamburg, Grindelallee 117, 20146, Hamburg, Germany.

Matthias Rottmann (M)

Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002, Basel, Switzerland.
Universität Basel, Petersplatz 1, 4003, Basel, Switzerland.

Matthias Witschel (M)

BASF-SE, Carl-Bosch-Strasse 38, 67056, Ludwigshafen, Germany.

Anna K H Hirsch (AKH)

Helmholtz Institute for Pharmaceutical Research (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University Campus E8.1, 66123, Saarbrücken, Germany.
Helmholtz International Lab for Anti-Infectives, Saarland University Campus E8.1, 66123, Saarbrücken, Germany.
Department of Pharmacy, Saarland University, Campus E8.1, 66123, Saarbrücken, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH